Eli Lilly Expands Obesity Drug Pipeline with Versanis Bio Acquisition
Eli Lilly, the leading pharmaceutical company globally, is enhancing its obesity drug pipeline through the acquisition of Versanis Bio, a ...
Eli Lilly, the leading pharmaceutical company globally, is enhancing its obesity drug pipeline through the acquisition of Versanis Bio, a ...